Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children

Status Completed

Clinical Trial Summary

The investigators believe a readily available drink containing a high dose of probiotics has the potential to improve compliance through many of these mechanisms. This product also has the potential to positively impact the health of children and adults around the world, as yogurt will likely be more appealing to both children and their parents for long term consumption than pharmaceutical-like preparations. In addition to the benefits associated with the consumption of probiotics, there is an increased health benefit from consuming yogurt, a nutrient dense food. More specifically, the rationale for this Phase I study is to determine safety of this yogurt drink and comply with FDA recommendations pertaining to an Investigational New Drug application. The investigators hypothesize that BB-12 is safe in generally healthy children ages 1-5 years.

Clinical Trial Description

Probiotics are live microorganisms that, when administered in sufficient amounts, may improve health. A common use for probiotics is in addressing gastrointestinal issues, such as antibiotic-associated diarrhea (AAD). As an alternative to supplements, probiotics are also included as ingredients in fermented dairy products to produce functional foods, which are foods providing health benefits beyond their nutritional value. Yogurt, for example, is a fermented milk product often considered a functional food. One of the most commonly used probiotics is Bifidobacterium animalis ssp. lactis (BB-12). Our Primary Aim in Years 1-2 is to conduct a pediatric randomized controlled study to establish the safety of BB-12 fortified yogurt in children. Our Secondary Aims are to examine the fecal microbiota of children prior to, during and following consumption of probiotics. This study will evaluate whether a well-defined, probiotic-containing yogurt can safely be used as an effective delivery vehicle for probiotics. This study is important to help advance probiotic research forward in a systematic, well-accepted manner. Our long-term goal is to create yogurt with sufficient probiotic dosages to positively impact many different aspects of childhood and adult health. ;

Study Design

Related Conditions & MeSH terms

Children

Clinical Trial Details

NCT number	NCT01652287
Study type	Interventional
Source	Georgetown University
Contact
Status	Completed
Phase	Phase 1
Start date	February 2013
Completion date	July 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03563196` - Diagnosis Of Pulmonary Complications After Cardiac Surgery In Children
Completed	`NCT02553486` - Internationally Adopted Children Quality of Life	N/A
Completed	`NCT02903134` - Early Risk of Asthma in Children Exposed to In-utero Maternal Obesity
Completed	`NCT02918890` - Intensive Unimanual (CIMT) and Bimanual Training (HABIT) in Children With Hemiplegia	N/A
Active, not recruiting	`NCT01874847` - PLAY GAME: Post-concussion Syndrome in Youth - Assessing the GABAergic Effects of Melatonin	Phase 2/Phase 3
Enrolling by invitation	`NCT01971827` - Effectiveness of a Physical Activity Intervention to Prevent Obesity and Improve Academic Performance	N/A
Enrolling by invitation	`NCT01971840` - Effectiveness of a Physical Activity Intervention on Preventing Obesity During the Adiposity Rebound Period.	N/A
Completed	`NCT01738308` - The Effects of Healing Touch on Post Operative Pediatric Patients	N/A
Completed	`NCT01693926` - Effect of Physical Activity an Stress in Children	N/A
Completed	`NCT01943760` - Tamadol Wound Infiltration in Children Under Inguinal Hernioplasty	Phase 4
Completed	`NCT01864811` - Effect of Baby-CIMT in Infants Younger Than 12 Months	N/A
Completed	`NCT01323010` - Efficacy and Safety of Increasing Doses of Inhaled Albuterol in Children With Acute Wheezing Episodes	N/A
Completed	`NCT01277224` - Effectiveness of a Physical Activity Intervention on the Obesity of Schoolchildren	N/A
Active, not recruiting	`NCT00989547` - Cord Blood Infusion for Type 1 Diabetes Mellitus (T1DM)	Phase 1
Completed	`NCT04051723` - Pre-emptive Scalp Infiltration With Dexamethasone Plus Ropivacaine for Post-Craniotomy Pain in Children	Phase 4
Completed	`NCT03236363` - Effectiveness of MOVI Interventions on Adiposity, Cognition and Motor Competence: MOVI-da10!	N/A
Completed	`NCT03236337` - Effectiveness of MOVI Interventions on Adiposity, Cognition and Subclinical Atherosclerosis: MOVI-daFit!	N/A
Not yet recruiting	`NCT03427697` - Effect of VR and Accommdation Relax on Controlling Myopia in Children	N/A
Completed	`NCT05603507` - Inspiratory Muscle Training in Children With Chest Burn	N/A
Not yet recruiting	`NCT06267339` - Effects of Transcranial Random Noise Stimulation on Motor Learning in Typically Developing Adolescents	Early Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.